Search Browse Earnings

Petros Pharmaceuticals, Inc.

OTC:PTPI

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Petros Pharmaceuticals, Inc. — SlamSEC

Revenue

$5.8M

-2.8% YoY

FY 2024

Adj. EBITDA

-$10.3M

-177.5% margin

FY 2024

Net Income

-$8.2M

-140.2% margin

FY 2024

EPS (Diluted)

-$6.35

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$13.3M

FY 2024

Total Debt

$14.0M

FY 2024

Net Debt

$695,418

FY 2024

Enterprise Value

—

Debt / EBITDA

-0.1x

FY 2024

EV / EBITDA

—

Employees

—